Projects per year
Fingerprint
Dive into the research topics where Nick Devoogdt is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
HERC58: SPECY-SORT: SPEctral flow CYtometer and cell SORTer
Laoui, D., De Veirman, K., Van der Henst, C., Brunner, J., Messens, J., Raes, G., Van Ginderachter, J., Devoogdt, N., Magez, S., Remaut, H. K., Stijlemans, B., Movahedi, K., Peeters, E. & De Trez, C.
1/05/22 → 30/04/26
Project: Fundamental
-
HERC59: CASA PETIt: CAmera for Small Animal PET-Imaging
Devoogdt, N., Raes, G., Lahoutte, T., Van Ginderachter, J., Caveliers, V., Keyaerts, M., Hernot, S. & D'Huyvetter, M.
1/05/22 → 30/04/26
Project: Fundamental
-
HERC56: Intravital imaging as tool to bridge the gap between macroscopic in vivo imaging and microscopic tissue analysis
Hernot, S., Staels, W., Hellemans, K., Smolders, I., Rooman, I., Devoogdt, N., Menu, E., De Bundel, D., Breckpot, K., De Leu, N., Movahedi, K., D'Huyvetter, M. & De Kock, J.
1/05/22 → 30/04/26
Project: Fundamental
-
OZR3941: Cofinanciering OZR FWO Hercules MZW: SPECY-SORT: SPEctral flow CYtometer and cell SORTer
Laoui, D., Van Ginderachter, J., Movahedi, K., De Veirman, K., Magez, S., De Trez, C., Stijlemans, B., Raes, G., Devoogdt, N., Messens, J., Brunner, J., Remaut, H. K., Fioravanti, A., Peeters, E. & Van der Henst, C.
16/03/22 → 16/03/25
Project: Fundamental
-
FWOAL1045: Nanobody-based AXL targeting and combination treatment for acute myeloid leukemia and multiple myeloma
De Veirman, K., Devoogdt, N. & Vanderkerken, K.
1/01/22 → 31/12/25
Project: Fundamental
Research output
-
Emerging applications of nanobodies in cancer therapy
Awad, R. M., Meeus, F., Ceuppens, H., Ertveldt, T., Hanssens, H., Lecocq, Q., Mateusiak, L., Zeven, K., Valenta, H., De Groof, T. W. M., De Vlaeminck, Y., Krasniqi, A., De Veirman, K., Goyvaerts, C., D'Huyvetter, M., Hernot, S., Devoogdt, N. & Breckpot, K., 2022, In : International review of cell and molecular biology. 369, p. 143-199 57 p.Research output: Contribution to journal › Article
-
Expanding Theranostic Radiopharmaceuticals for Tumor Diagnosis and Therapy
Barca, C., Griessinger, C. M., Faust, A., Depke, D., Essler, M., Windhorst, A. D., Devoogdt, N., Brindle, K. M., Schäfers, M., Zinnhardt, B. & Jacobs, A. H., Jan 2022, In : Pharmaceuticals. 15, 1, 20 p., 13.Research output: Contribution to journal › Article
Open Access3 Citations (Scopus) -
Preclinical validation of [18F]-FB-(Anti Human PD-L1) Nanobody for PET imaging
Dierick, H., Breckpot, K., Devoogdt, N., Keyaerts, M., Caveliers, V., Lahoutte, T. & Bridoux, J., 22 May 2022.Research output: Unpublished contribution to conference › Poster
Open Access -
Targeted radionuclide therapy with low and high-dose Lutetium-177 labeled single domain antibodies induces distinct immune signatures in a mouse melanoma model
Ertveldt, T., De Beck, L., De Ridder, K., Locy, H., De Mey, W., Goyvaerts, C., Lecocq, Q., Ceuppens, H., De Vlaeminck, Y., Awad, R. M., Keyaerts, M., Devoogdt, N., D'Huyvetter, M., Breckpot, K. & Krasniqi, A., 2022, In : Molecular Cancer Therapeutics.Research output: Contribution to journal › Article
Open Access -
The road to personalized myeloma medicine: Patient-specific single-domain antibodies for anti-idiotypic radionuclide therapy
Puttemans, J., Stijlemans, B., Keyaerts, M., Vander Meeren, S., Renmans, W., Fostier, K., Debie, P., Hanssens, H., Rodak, M., Pruszynski, M., De Veirman, K., Vanderkerken, K., Lahoutte, T., Morgenstern, A., Bruchertseifer, F., Devoogdt, N. & D'Huyvetter, M., Jan 2022, In : Molecular Cancer Therapeutics. 21, 1, p. 159-169 11 p.Research output: Contribution to journal › Article
Open AccessFile4 Citations (Scopus)60 Downloads (Pure)
Prizes
-
Alavi-Mandell Award from Journal of Nuclear Medicine
Ahmet Krasniqi (Recipient), Matthias D'Huyvetter (Recipient), Nick Devoogdt (Recipient) & Marleen Keyaerts (Recipient), 16 Apr 2019
Prize: Prize (including medals and awards)
-
Certificat of Young Speaker Award
Quentin Lecocq (Recipient), Katrijn Broos (Recipient), Jessica Bridoux (Recipient), Geert Raes (Recipient), Catarina Xavier (Recipient), Nick Devoogdt (Recipient), Marleen Keyaerts (Recipient) & Karine Breckpot (Recipient), 1 Feb 2019
Prize: Prize (including medals and awards)
File -
ESMI presentation award for best oral presentation
Jessica Bridoux (Recipient), Katrijn Broos (Recipient), Quentin Lecocq (Recipient), Maxine Crauwels (Recipient), Charlotte Martin (Recipient), Frederik Cleeren (Recipient), Mikhail Kondrashov (Recipient), Steven Ballet (Recipient), G. Bormans (Recipient), Magnus Schou (Recipient), Chad Elmore (Recipient), Geert Raes (Recipient), Karine Breckpot (Recipient), Serge Muyldermans (Recipient), Nick Devoogdt (Recipient), Marleen Keyaerts (Recipient), Vicky Caveliers (Recipient) & Catarina Xavier (Recipient), 17 Jan 2020
Prize: Prize (including medals and awards)
-
Knowledge for Growth 2018 Ghent - poster award
Katrijn Broos (Recipient), Quentin Lecocq (Recipient), Jessica Bridoux (Recipient), Geert Raes (Recipient), Catarina Xavier (Recipient), Marleen Keyaerts (Recipient), Nick Devoogdt (Recipient) & Karine Breckpot (Recipient), 18 May 2018
Prize: Prize (including medals and awards)
-
Non-invasive imaging of atherosclerosis with Nanobodies
Jens De Vos (Recipient) & Nick Devoogdt (Recipient), 25 Nov 2010
Prize: Other distinction
Activities
-
Using the site-specific radiolabeling of a PD-L1 nanobody via maleimide–cysteine chemistry to develop a PET-tracer as screening tool for personalized oncology treatment
Dora Mugoli Chigoho (Speaker), Jessica Bridoux (Speaker), Catarina Xavier (Speaker), Vicky Caveliers (Speaker), Marleen Keyaerts (Speaker), Nick Devoogdt (Speaker), Karine Breckpot (Speaker), Robin Maximilian Awad (Speaker), Quentin Lecocq (Speaker)7 May 2022Activity: Talk or presentation › Talk or presentation at a conference
-
Preclinical validation of [18F]-FB-(Anti Human PD-L1) Nanobody for PET imaging
Herlinde Dierick (Speaker), Karine Breckpot (Contributor), Nick Devoogdt (Contributor), Marleen Keyaerts (Contributor), Vicky Caveliers (Contributor), Tony Lahoutte (Contributor), Jessica Bridoux (Contributor)7 May 2022Activity: Talk or presentation › Talk or presentation at a conference
-
Granted Project Scientific Fund Willy Gepts: Development of a nanoCAR-T cell approach for the treatment of multiple myeloma
Heleen Hanssens (Supervisor), Nick Devoogdt (Supervisor), Karine Breckpot (Supervisor)1 Jan 2022 → 1 Jan 2026Activity: Other
-
Human relevant models for drug research and development
Fien Meeus (Speaker), Robin Maximilian Awad (Contributor), Nick Devoogdt (Contributor), Sandra Tuyaerts (Contributor), Cleo Goyvaerts (Contributor), Yannick De Vlaeminck (Contributor), Bart Neyns (Contributor), Karine Breckpot (Contributor)8 Oct 2021Activity: Talk or presentation › Talk or presentation at a workshop/seminar
-
Biomolecules (Journal)
Nick Devoogdt (Editor), Serge Muyldermans (Editor), Timo De Groof (Editor), Sophie Hernot (Editor)2021 → …Activity: Publication peer-review and editorial work › Editorial activity
Press / Media
-
Betaalbare kankerimmunotherapie
Karine Breckpot, Nick Devoogdt, Yannick De Vlaeminck & Fien Meeus
8/02/22
1 item of Media coverage
Press/Media: Research
-
VUB-onderzoekers en start-up Esobiotec willen kankerimmunotherapie betaalbaarder maken
Karine Breckpot, Nick Devoogdt, Fien Meeus & Yannick De Vlaeminck
31/01/22
1 item of Media coverage
Press/Media: Research
-
VUB-onderzoekers en start-up Esobiotec streven naar betaalbare kankerimmunotherapie
Karine Breckpot, Nick Devoogdt, Yannick De Vlaeminck & Fien Meeus
31/01/22
1 Media contribution
Press/Media: Research
-
EsoBiotec ready to transform cell therapy cancer treatments
Karine Breckpot & Nick Devoogdt
30/09/21
1 item of Media coverage
Press/Media: Research
-
Mini-antibodies discovered in sharks and camels could lead to drugs for cancer and other diseases
10/05/18
1 Media contribution
Press/Media: Research
Thesis
-
Analysis of the metastasis-promoting effect of human secretory leukocyte protease inhibitor.
Author: Jing, Z., De Baetselier, P. & Devoogdt, N., 2001Supervisor: De Baetselier, P. (Promotor) & Devoogdt, N. (Co-promotor)
Student thesis: Master's Thesis
-
A novel generation of affitins for targeting cancer cells with drug-loaded lipid nanocapsules
Author: Kalichuk, V., Pecorari, F., Préat, V. & Devoogdt, N., 16 Oct 2017Student thesis: Doctoral Thesis
-
Assessment of antigen-binding domain parameters important for adequate CAR-T-cell activation: evaluating different SLAMF7-targeting nanobodies.
Author: Meeus, F., Hanssens, H., De Veirman, K. & Devoogdt, N., 19 Jun 2020Supervisor: Hanssens, H. (Advisor)
Student thesis: Master's Thesis
-
Assessment of properties affecting the differential biodistribution and pharmacokinetic clearance of nanobodies via the kidneys by generating chimeras.
Author: Tchafack Kaze, J. M., Muyldermans, S., Devoogdt, N. & Vincke, C., Jan 2013Supervisor: Muyldermans, S. (Promotor), Devoogdt, N. (Co-promotor) & Vincke, C. (Advisor)
Student thesis: Master's Thesis
-
Bead based immunoassay of HER2 ECD domain using nanobodies
Author: Adaga, E., Muyldermans, S., De Pauw, P. & Devoogdt, N., 1 Sep 2015Student thesis: Master's Thesis